PT-141 (Bremelanotide)
Reported Onset
2–4 weeks
Primary Use
Libido enhancement and sexual arousal in both men and women.
Dose
1mg - 2mg
Frequency
As needed, 45 minutes before activity
Kisspeptin
Reported Onset
2–4 weeks
Primary Use
Reproductive hormone regulation, fertility support, and libido enhancement.
Dose
1nmol/kg - 10nmol/kg
Frequency
Pulsatile or as per fertility protocol
Community Verdict
Both enhance sexual function but via different pathways — GnRH vs MCR. The community generally selects between PT-141 (Bremelanotide) and Kisspeptin based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for PT-141 (Bremelanotide) or Kisspeptin at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified